Cargando…

COVID-19 severity and outcome in multiple sclerosis: Results of a national, registry-based, matched cohort study

BACKGROUND: Risk factors associated with coronavirus disease 2019 (COVID-19) severity in patients with multiple sclerosis (MS) have been described. Recent improvements in supportive care measures and increased testing capacity may modify the risk of severe COVID-19 outcome in MS patients. This retro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pérez, Carlos A., Zhang, Guo-Qiang, Li, Xiaojin, Huang, Yan, Lincoln, John A., Samudralwar, Rohini D., Gupta, Rajesh K., Lindsey, John W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366056/ https://www.ncbi.nlm.nih.gov/pubmed/34418735 http://dx.doi.org/10.1016/j.msard.2021.103217

Ejemplares similares

Commentary: The spectrum of neurological manifestations related to COVID-19 and vaccinations
por: Samudralwar, Rohini D.
Publicado: (2021)

Familial aggregation of multiple sclerosis: Results from the national registry of the disease in Saudi Arabia
por: AlJumah, Mohammed, et al.
Publicado: (2020)

Predicting multiple sclerosis severity with multimodal deep neural networks
por: Zhang, Kai, et al.
Publicado: (2023)

The Danish Multiple Sclerosis Registry
por: Magyari, Melinda, et al.
Publicado: (2020)

Epidemiology of familial multiple sclerosis in Iran: a national registry-based study
por: Salehi, Zahra, et al.
Publicado: (2022)

COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry
por: Bsteh, Gabriel, et al.
Publicado: (2021)

Implementing coronavirus disease 2019 scale-up registry protocol in national multiple sclerosis registry system of Iran
por: Eskandarieh, Sharareh, et al.
Publicado: (2021)

Prevalence of multiple sclerosis in Croatia: data from national and non-governmental organization registries
por: Benjak, Tomislav, et al.
Publicado: (2018)

SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry
por: Arrambide, Georgina, et al.
Publicado: (2021)

The German Multiple Sclerosis and Pregnancy Registry: rationale, objective, design, and first results
por: Thiel, Sandra, et al.
Publicado: (2021)

Impact of the National Amyotrophic Lateral Sclerosis Registry: Analysis of Registry‐funded Research
por: Rechtman, Lindsay, et al.
Publicado: (2022)

Preliminary Results of National Amyotrophic Lateral Sclerosis (ALS) Registry Risk Factor Survey Data
por: Bryan, Leah, et al.
Publicado: (2016)

Incidence of malignancy in multiple sclerosis: A cohort study in the Danish Multiple Sclerosis Registry
por: Nørgaard, Mette, et al.
Publicado: (2021)

The Danish National Multiple Myeloma Registry
por: Gimsing, Peter, et al.
Publicado: (2016)

Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry
por: Vališ, Martin, et al.
Publicado: (2022)

Validation of the multiple sclerosis diagnosis in the Norwegian Patient Registry
por: Benjaminsen, Espen, et al.
Publicado: (2019)

TrkB Isoforms Differentially Affect AICD Production through Their Intracellular Functional Domains
por: Ansaloni, Sara, et al.
Publicado: (2011)

Self-reported quality of life in multiple sclerosis patients: preliminary results based on the Polish MS Registry
por: Brola, Waldemar, et al.
Publicado: (2016)

Autoinjector preference among patients with multiple sclerosis: results from a national survey
por: Limmroth, V, et al.
Publicado: (2017)

Prevalence and characteristics of tremor in the NARCOMS multiple sclerosis registry: a cross-sectional survey
por: Rinker, John R, et al.
Publicado: (2015)

Experiences of persons with multiple sclerosis with the Covid-19 vaccination: A cross-sectional study of the Swiss Multiple Sclerosis Registry
por: Stanikić, Mina, et al.
Publicado: (2023)

CDC Grand Rounds: National Amyotrophic Lateral Sclerosis (ALS) Registry Impact, Challenges, and Future Directions
por: Mehta, Paul, et al.
Publicado: (2017)

National registry for amyotrophic lateral sclerosis: a systematic review for structuring population registries of motor neuron diseases
por: Barbalho, Ingridy, et al.
Publicado: (2021)

Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: An MSBase registry substudy
por: Lizak, Nathaniel, et al.
Publicado: (2020)

Multiple sclerosis in Kenya: Demographic and clinical characteristics of a registry cohort
por: Jamal, Imran, et al.
Publicado: (2021)

Registry of patients with multiple sclerosis and COVID-19 infection in Saudi Arabia
por: Alshamrani, Foziah, et al.
Publicado: (2021)

Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study
por: Rivera, Victor M, et al.
Publicado: (2013)

Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European Interferon-beta Pregnancy Registry
por: Hellwig, Kerstin, et al.
Publicado: (2020)

Multiple sclerosis in Latin America: A different disease course severity? A collaborative study from the MSBase Registry
por: Rojas, Juan Ignacio, et al.
Publicado: (2015)

Pediatric-onset multiple sclerosis in Egypt: a multi-center registry of 186 patients
por: Hamdy, Sherif M, et al.
Publicado: (2018)

Long‐term outcome after COVID‐19 infection in multiple sclerosis: A nation‐wide multicenter matched‐control study
por: Bsteh, Gabriel, et al.
Publicado: (2022)

The multiple sclerosis relapse experience: patient-reported outcomes from the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry
por: Nickerson, Molly, et al.
Publicado: (2013)

Pregnancy Outcomes in Patients With Multiple Sclerosis Exposed to Natalizumab—A Retrospective Analysis From the Austrian Multiple Sclerosis Treatment Registry
por: Guger, Michael, et al.
Publicado: (2020)

Characteristics and predictors of progression in an Egyptian multiple sclerosis cohort: a multicenter registry study
por: Hamdy, Sherif M, et al.
Publicado: (2017)

Chances and Challenges of Registry-Based Pharmacovigilance in Multiple Sclerosis: Lessons Learnt from the Implementation of the Multicenter REGIMS Registry
por: Simbrich, Alexandra, et al.
Publicado: (2020)

Colorectal Cancer Survival in Multiple Sclerosis: A Matched Cohort Study
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Functional assessment of the dural lymphatic vessels using dynamic contrast MRI in multiple sclerosis
por: Gabr, Refaat E., et al.
Publicado: (2023)

Restless legs syndrome severity in the National RLS Opioid Registry during the COVID-19 pandemic()
por: Wipper, Benjamin, et al.
Publicado: (2022)

Prognostic Factors in Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis with Severe Glomerular Sclerosis: A National Registry-Based Cohort Study
por: Bjørneklett, Rune, et al.
Publicado: (2018)

Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry
por: Spelman, Tim, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s3uv3un2nnumjuoqaerj7r5kq5